Mani Executive and Leadership Team

Takaaki Ishiyama, the Chief Executive Officer at Mani, directs the overarching corporate strategy for the medical device manufacturer. Ishiyama oversees the alignment of production capabilities with international medical standards to ensure the delivery of high-quality surgical needles and precision instruments. By fostering partnerships with global healthcare providers, the Chief Executive Officer drives market expansion across diverse regions. Takaaki Ishiyama maintains a focus on long-term growth through the optimization of manufacturing processes and the integration of advanced wire material technologies. This leadership role involves constant collaboration with the Board to refine the company mission and enhance operational efficiency. Through the implementation of rigorous quality control protocols, the Chief Executive Officer ensures that every product meets the stringent requirements of medical professionals worldwide. Ultimately, Ishiyama secures the competitive position of the firm within the global medical device industry.

Toshihide Takai, the President, Chief Executive Officer & Managing Director & Chief Operating Officer at Mani, manages the daily operational execution and organizational infrastructure. Takai coordinates the complex supply chain logistics required for the production of dental and ophthalmic equipment. Overseeing the internal scaling of manufacturing facilities, the President, Chief Executive Officer & Managing Director & Chief Operating Officer ensures that production output matches the rising demand from international markets. Toshihide Takai drives the implementation of lean manufacturing principles to reduce waste and improve precision processing technology. This role requires constant interaction with department heads to synchronize production schedules with corporate objectives. By streamlining operational workflows, the President, Chief Executive Officer & Managing Director & Chief Operating Officer maintains the high safety standards expected by medical professionals. Takai consistently monitors performance metrics to guarantee that operational efficiency supports the broader financial goals of the organization.

Tomomi Kosaka, the Senoir Vice President and Executive Officer Chief Marketing Officer at Mani, architects the global brand strategy and market positioning for surgical instruments. Kosaka directs the outreach initiatives that connect the company with medical professionals across various international territories. Overseeing the development of digital and physical marketing campaigns, the Senoir Vice President and Executive Officer Chief Marketing Officer ensures that the value proposition of precision-engineered medical devices reaches target audiences effectively. Tomomi Kosaka analyzes market trends to identify new opportunities for product adoption in emerging healthcare sectors. This leadership role involves close coordination with the research division to translate technical product advantages into compelling narratives for clinicians. By managing the global brand identity, the Senoir Vice President and Executive Officer Chief Marketing Officer drives revenue growth and strengthens the market presence of the firm. Kosaka maintains a focus on customer engagement to ensure long-term loyalty.

Hideshi Fukumoto, the Chief Technology Officer & Head Research Development Division & Senior Managing Executive Officer at Mani, leads the innovation pipeline for surgical needles and wire material processing. Fukumoto directs the research teams in the creation of next-generation medical devices that meet evolving clinical needs. Overseeing the entire development lifecycle, the Chief Technology Officer & Head Research Development Division & Senior Managing Executive Officer ensures that new technologies adhere to strict international safety standards. Hideshi Fukumoto collaborates with the executive team to align technical breakthroughs with the long-term product roadmap of the company. This role involves managing the intellectual property portfolio and fostering a culture of continuous improvement within the laboratory environment. By driving advancements in precision manufacturing, the Chief Technology Officer & Head Research Development Division & Senior Managing Executive Officer maintains the technological edge of the firm. Fukumoto ensures that research outcomes directly translate into improved patient care and surgical efficacy.